Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted genome modification via triple helix formation.

Jennifer M Kalish1, Peter M Glazer

  • 1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510, USA.

Annals of the New York Academy of Sciences
|January 6, 2006
PubMed
Summary

Triplex-forming oligonucleotides (TFOs) offer precise gene modification by targeting specific DNA sequences. These molecules can directly alter chromosomal DNA or facilitate gene correction through induced recombination, enhancing therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myogenic dysregulation underlies tongue overgrowth in Beckwith-Wiedemann syndrome.

bioRxiv : the preprint server for biology·2026
Same author

Beckwith-Wiedemann syndrome multiomic analysis of hepatoblastoma uncovers unique tumour heterogeneity and cellular landscapes, including transition cells leading to tumour formation.

BJC reports·2026
Same author

The Clinical Staging Model in Psychosis: a Cross-Disciplinary Critical Appraisal Informed by Oncology.

Schizophrenia bulletin·2026
Same author

Investigating the role of mimosine-induced genotoxic stress through DNA repair profiling.

Molecular therapy. Nucleic acids·2026
Same author

A mixed methods study of the impact of WAGR spectrum disorder on individuals and their caregivers.

Orphanet journal of rare diseases·2026
Same author

High-Resolution Genomic Characterization of WAGR Spectrum Disorder: Insights From a Novel Cohort and Literature Synthesis, and Validation of Patient-Reported Data.

American journal of medical genetics. Part A·2026

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Triplex-forming oligonucleotides (TFOs) bind sequence-specifically to duplex DNA.
  • TFOs have shown potential for site-specific gene modification.
  • Previous research explored TFOs for delivering mutagenic agents.

Purpose of the Study:

  • To explore the mechanisms of TFO-mediated gene modification.
  • To investigate TFOs' ability to induce changes in chromosomal DNA.
  • To assess the potential of TFOs for gene correction and therapeutic applications.

Main Methods:

  • Utilizing TFOs for sequence-specific DNA binding.
  • Investigating TFO-induced recombination between target and donor DNA.
  • Developing chemical modifications on TFOs to expand target sites.

Related Experiment Videos

  • Exploring novel TFO delivery techniques.

    • Main Results:

    • TFOs can induce gene modification in chromosomal DNA through triple helix formation.
    • TFOs facilitate gene modification at a distance from the binding site via induced recombination.
    • Chemical modifications and delivery advancements are increasing TFO effectiveness and target range.

    Conclusions:

    • TFOs are versatile tools for targeted gene modification.
    • Further development in TFO chemistry and delivery enhances their therapeutic prospects for gene correction.
    • TFOs hold significant promise for advancing genetic engineering and personalized medicine.